Intratympanic Injections of Dexamethasone in Delayed Endolymphatic Hydrops: A Prospective Clinical Study

被引：3

作者：

Morgan, Ashraf Elsayed ^{[1
]}

Ismail, Elshahat Ibrahem ^{[1
]}

Ashraf, Bassem ^{[1
]}

机构：

[1] Mansoura Univ, Fac Med, ENT Dept, Mansoura, Egypt

来源：

ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY | 2018年 / 80卷 / 01期

关键词：

Intratympanic dexamethasone; Intratympanic injection; Delayed endolymphatic hydrops; Vertigo management; MENIERES-DISEASE; TOPICAL GENTAMICIN; INNER-EAR; THERAPY; VERTIGO; ONSET;

D O I：

10.1159/000486373

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

Objective: This study was designed to evaluate the effectiveness of intratympanic dexamethazone (ITD) for the treatment of ipsilateral delayed endolymphatic hydrops (DEH). Methods: Forty-one patients were diagnosed with ipsilateral DEH. Only 37 patients completed this study. Patients were randomly divided into 2 groups. Group A (n = 16) received oral medication, and group B (n = 21) received ITD once weekly for 4 consecutive weeks. Results: In group A, 6 patients showed improvement in their vertigo. Four patients (25%) showed complete vertigo control, and 2 patients (12.5%) showed substantial vertigo control. In group B, 21 patients showed improvement in their vertigo, 11 patients (52%) showed complete vertigo control, and 10 patients (47%) showed substantial vertigo control. Only 1 case did not show any improvement in their vertigo. Conclusion: ITD is proven to be a valuable and promising alternative modality for the management of ipsilateral DEH. (C) 2018 S. Karger AG, Basel.

引用

页码：19 / 27

页数：9

共 21 条

[1]

BAGGERSJOBACK D, 1990, AM J OTOL, V11, P406

[2] Intratympanic gentamicin therapy for vertigo in nonserviceable ears [J].